Oramed Pharmaceuticals
ORMP
#8876
Rank
NZ$0.14 B
Marketcap
$3.68
Share price
-2.69%
Change (1 day)
7.64%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): NZ$40.62 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of NZ$12.08 Million, an increase over its 2022 earnings that were of -NZ$62.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$40.62 M236.17%
2023 NZ$12.08 M-119.45%
2022 -NZ$62.13 Million39.17%
2021 -NZ$44.64 Million73.93%
2020 -NZ$25.67 Million18.53%
2019 -NZ$21.66 Million-16.62%
2018 -NZ$25.97 Million38.32%
2017 -NZ$18.78 Million12.51%
2016 -NZ$16.69 Million25.01%
2015 -NZ$13.35 Million18.18%
2014 -NZ$11.3 Million39.72%
2013 -NZ$8.09 Million46.4%
2012 -NZ$5.53 Million128.32%
2011 -NZ$2.42 Million-51.47%
2010 -NZ$4.99 Million35.21%
2009 -NZ$3.69 Million
2007 -NZ$5.8 Million607.04%
2006 -NZ$0.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.58 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
NZ$12.56 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$0.87 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-NZ$0.35 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA